Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
08/2003
08/07/2003US20030148311 Aspartate carbamyltransferase as herbicidal target
08/07/2003US20030148306 Aggrecanase molecules
08/07/2003US20030148300 Encoded by nucleic acid molecule of given sequence; use in producing transgenic plants with increased levels of tocopherol
08/07/2003US20030148295 Endothelial cells; nucleotide sequences; microarrays; algorithms
08/07/2003US20030148283 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
08/07/2003US20030148275 Nuclease
08/07/2003US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein
08/07/2003US20030148270 Genes from the 20q13 amplicon and their uses
08/07/2003US20030147895 Constructs for delivery of threrapeutic agents to neuronal cells
08/07/2003US20030147876 Combination of a growth factor and a protease enzyme
08/07/2003US20030147875 Sulfatases and methods of use thereof
08/07/2003US20030147874 A targeted beta-lactamase enzyme can converting a prodrug to a drug product; used as antiproliferative disorder, anticarcinogenic agent treating cancer, treating autoimmune disease or infectious diseases
08/07/2003US20030147856 Proteins
08/07/2003US20030147853 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2483332A1 Cell extract for cell-free protein synthesis and process for producing the same
08/07/2003CA2480126A1 Cell culture medium for lymphoid cells
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474466A1 Germ extract for cell-free protein synthesis and process for producing the same
08/07/2003CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003CA2474007A1 Transgenic animals expressing prkag3
08/07/2003CA2474006A1 Variants of the alpha 1 subunit of human ampk
08/07/2003CA2474005A1 Prkag3 gene promoter and uses thereof
08/07/2003CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase
08/07/2003CA2473231A1 Resistance-repellent retroviral protease inhibitors
08/07/2003CA2465265A1 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1333093A2 Human muscle nad: arginine adpribosyltransferase
08/06/2003EP1333087A1 Crosslinked enzyme aggregates and crosslinking agent therefore
08/06/2003EP1332228A2 Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4 gene
08/06/2003EP1332221A1 Enzyme catalysis in the presence of ionic liquids
08/06/2003EP1332217A2 Novel bacterial phytases and method for producing same
08/06/2003EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
08/06/2003EP1332214A2 32144, a human fatty acid amide hydrolase and uses thereof
08/06/2003EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
08/06/2003EP1331924A2 Use of carotenoids for treating ageing symptoms
08/06/2003EP1331845A1 Barley with reduced ssii activity and starch containing products with a reduced amylopectin content
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003EP1015570A4 Fibrin microbeads and uses thereof
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0833940B1 Encoded reaction cassette
08/06/2003EP0804465B1 Novel elastase inhibitors
08/06/2003EP0788557A4 Rapid detection and identification of nucleic acid variants and pathogens
08/06/2003EP0728018B1 New enzymes and prodrugs for ADEPT
08/06/2003CN1434867A Rice peroxidases with varius characteristics
08/06/2003CN1434866A Rice-origin gibberellin 3beta-hydroxylase genes and utilization thereof
08/06/2003CN1434861A Bacterial isolates of genus kiebsiella, and isomaltulose synthase gene isolated therefrom
08/06/2003CN1434860A Process for producing L-amino acid and novel gene
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434678A Controlling offsprings sex ratio by targeting transgenes onto the sex chromosomes
08/06/2003CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid
08/06/2003CN1117154C Urokinase zymogen mutant
08/06/2003CN1117153C Thermophilic fungal expression system
08/06/2003CN1117152C Process for production L-lysine
08/06/2003CN1117151C Riboflavin synthesis in fungi
08/06/2003CN1117143C Coated enzyme preparation with improved solubility
08/05/2003US6603064 Nuclear male sterile plants, method of producing same and methods to restore fertility
08/05/2003US6603062 Introducing into monocotyledons nucleic acid molecules encoding a enzyme isolated from purple bacteria;
08/05/2003US6603060 Method for regulating cell death
08/05/2003US6602988 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602984 Human elastase IV
08/05/2003US6602843 Enzyme containing granule
08/05/2003US6602841 Granule with hydrated barrier material
08/05/2003US6602700 Phenolic acid esterases, coding sequences and methods
08/05/2003US6602698 Human kinase proteins and polynucleotides encoding the same
08/05/2003US6602696 Aspergillus tubigensis polygalacturonase
08/05/2003US6602695 Mutant enzymatic protein for use as tool in human therapeutics and diagnostics
08/05/2003US6602693 Gene encoding hyaluronan synthase
08/05/2003US6602689 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602682 Kluyveromyces as a host strain
08/05/2003US6602681 Reacting enzyme, of given amino acid sequence, produced by a recombinant DNA technique from Xenopus laevis
08/05/2003US6602677 Thermostable luciferases and methods of production
08/05/2003US6602502 Improved immunoassays of psychotomimetic drugs, narcotic drugs, tetrahydrocannabinols; use of the haptenic properties of psychoactive material; blood test N,N-Dimethyltryptamine and 5-Methoxy-N,N- Dimethyltryptamine
08/05/2003CA2202549C Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
07/2003
07/31/2003WO2003062468A2 Method for binding site identification using a multi-scale approach
07/31/2003WO2003062448A2 Sqv nucleic acids and polypeptides
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062433A2 Element for the s-phase and meristem specific expression of genes in plants and use thereof
07/31/2003WO2003062430A1 Fermentation of pentose sugars
07/31/2003WO2003062429A1 Novel serine protease
07/31/2003WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor
07/31/2003WO2003062413A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
07/31/2003WO2003062412A1 Sulfated fucan
07/31/2003WO2003062410A2 Torero protein
07/31/2003WO2003062409A2 Thermostable enzyme compositions
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062387A2 Thermotoga neapolitana xylose isomerase polypeptides and nucleic acids encoding same
07/31/2003WO2003062381A2 Multiply-substituted protease variants
07/31/2003WO2003062380A2 Multiply-substituted protease variants
07/31/2003WO2003062378A2 Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
07/31/2003WO2003062263A2 Aggrecanase-1 and -2 peptide substrates and methods
07/31/2003WO2003062173A2 Alanine 2,3- aminomutase
1 ... 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 ... 1416